RICHARD K. PRINS - 17 Oct 2025 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
Director
Signature
/s/ Richard Prins
Issuer symbol
IGC
Transactions as of
17 Oct 2025
Net transactions value
$0
Form type
4
Filing time
22 Oct 2025, 08:29:01 UTC
Previous filing
04 Jun 2025
Next filing
25 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PRINS RICHARD K Director 10224 FALLS ROAD, POTOMAC /s/ Richard Prins 22 Oct 2025 0001047579

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGC Options Award $0 +750,000 $0.000000 750,000 17 Oct 2025 Common Stock 750,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 750,000 options exercisable at $0.35, equally vesting over the next three years starting on March 31st, 2026.